GT Biopharma Inc.

05/16/2024 | Press release | Distributed by Public on 05/15/2024 21:58

XBRL Q1 2024

Quarterly report pursuant to Section 13 or 15(d)

Cover

Cover - shares

3 Months Ended

Mar. 31, 2024

May 15, 2024

Cover [Abstract]
Document Type 10-Q
Amendment Flag false
Document Quarterly Report true
Document Transition Report false
Document Period End Date Mar. 31, 2024
Document Fiscal Period Focus Q1
Document Fiscal Year Focus 2024
Current Fiscal Year End Date --12-31
Entity File Number 001-40023
Entity Registrant Name GT BIOPHARMA, INC.
Entity Central Index Key 0000109657
Entity Tax Identification Number 94-1620407
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 8000 Marina Blvd
Entity Address, Address Line Two Suite 100
Entity Address, City or Town Brisbane
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94005
City Area Code 415
Local Phone Number 919-4040
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol GTBP
Security Exchange Name NASDAQ
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Small Business true
Entity Emerging Growth Company false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 1,416,651